Nirmala Sitharaman earmarked ₹35,000 crore toward Covid-19 vaccines in Union Budget 2021. “I am committed to provide further funds if required,” she said, adding that two more vaccines will be rolled out soon. Currently, India has granted emergency use authorisation for Covaxin, developed by Hyderabad-based Bharat Biotech, and Covishield, manufactured by the Serum Institute of India in Pune.
Continue reading your story on the app
Continue reading your story in the magazine
EARNING HIS STRIPES
Following the success of The White Tiger, newcomer Adarsh Gourav finds himself in haloed territory of global award nominations
Forbes INDIA Leadership Awards 2020-21
In a year when business leaders were forced to overhaul their strategies from growth to survival mode, the Forbes India Leadership Awards honour those who successfully navigated the pandemic by innovating and leading from the front
‘COVID-19 SPED UP EXISTING TRENDS IN THE MARKET'
Jean-Christophe Babin, CEO of the Bvlgari Group, on the impact of the pandemic on the luxury sector
How LTI Came Into Its Own
With Sanjay Jalona at the helm, the IT services company is winning against bigger rivals, stepping out of its larger parent’s shadow, and forging an identity for itself
Valuations of Consumer Companies in Slow Lane
Despite a bright business outlook, FMCG companies have not outperformed the markets
‘If You Don't Understand Technology or Data, You'll Become Obsolete'
Raja Rajamannar, CMO at Mastercard, talks about his book Quantum Marketing, and how marketers can stay relevant in the future
From Noun To Verb: Can Dunzo Do A Zoom?
It has raised close to ₹880 crore in six years, earned ₹27.5 crore and lost ₹338.4 crore. Critics may scoff, but Dunzo’s backers are not complaining, and co-founder Kabeer Biswas is chilled out
Bitcoin Gets A Shot In The Arm
Tesla’s $1.5 billion investment in cryptocurrency will encourage more corporates to gamble with it. Experts say India needs to join before it’s too late
Tech For Health: The Practo Way
With Covid-19 becoming a tipping point for business, the startup that helps people find and consult with doctors is doubling down on expanding and deepening its tech platforms
Can Koo Be King?
Forbes India delves deep into the new bird app and its content moderation policy to find out if the migration from Twitter will stick